BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 10557064)

  • 1. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
    Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
    Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
    Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multidrug resistance mechanisms in cell line HL-60/VCR].
    Zhu XH; Li JY; Xia XM; Zhu MQ; Geng MJ; Chen L; Zhang JQ
    Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
    Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
    Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein.
    Campone M; Vavasseur F; Le Cabellec MT; Meflah K; Vallette FM; Oliver L
    Leukemia; 2001 Sep; 15(9):1377-87. PubMed ID: 11516098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants.
    Nüssler V; Pelka-Fleisc R; Gieseler F; Hasmann M; Löser R; Gullis E; Stötzer O; Zwierzina H; Wilmanns W
    Leuk Lymphoma; 1998 Nov; 31(5-6):589-97. PubMed ID: 9922050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L).
    Perkins C; Kim CN; Fang G; Bhalla KN
    Blood; 2000 Feb; 95(3):1014-22. PubMed ID: 10648417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
    Wu CH; Rastegar M; Gordon J; Safa AR
    Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant.
    Duraj J; Takacsova X; Sedlak J; Sulikova M; Hunakova L; Bies J; Chorvath B
    Anticancer Res; 2000; 20(6B):4627-32. PubMed ID: 11205313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
    Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
    Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Bcl-2 in response to anthracycline treatment may contribute to an apoptosis-resistant phenotype in leukemic cell lines.
    Durrieu F; Belaud-Rotureau MA; Lacombe F; Dumain P; Reiffers J; Boisseau MR; Bernard P; Belloc F
    Cytometry; 1999 Jun; 36(2):140-9. PubMed ID: 10554162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein.
    Fu CH; Martin-Aragon S; Weinberg KI; Ardi VC; Danenberg PV; Avramis VI
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):123-33. PubMed ID: 11561778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
    den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
    Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA; Sun RJ; Rishi AK; Dawson MI; Ordónez JV; Zhang Y; Tschang SH; Bhalla K; Han Z; Wyche J; Poirer G; Sheikh MS; Shroot B; Reichert U
    Oncol Res; 1998; 10(6):313-24. PubMed ID: 9848102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis.
    Jia L; Macey MG; Yin Y; Newland AC; Kelsey SM
    Blood; 1999 Apr; 93(7):2353-9. PubMed ID: 10090946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
    Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
    Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
    Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.